Abstract
Introduction: Ensuring patients have enough information about healthcare choices prior to completing a preference study is necessary to support the validity of the findings. Patients are commonly informed using text-based information with supporting graphics. Video-based information may be more engaging for the general patient population. This study aimed to assess (1) the impact that educating patients using video-based educational materials with a voiceover has on patient preferences compared to traditional text, and (2) whether this impact is consistent between two countries. Materials and Methods: A video-based educational tool was developed to inform patients prior to completing a discrete choice experiment assessing preferences for glucose monitors. Patients with diabetes from the Netherlands and Poland were recruited through an online research panel. Respondents were randomised to receive information in either a text or a video with animations and a voiceover. Data were analysed using a mixed-logit model. Results: N = 981 completed surveys were analysed from the Netherlands (n = 459) and Poland (n = 522). Differences were found between the countries, but no interpretable pattern of differences was found between the two types of educational materials. Patients spent less time in the educational material than would be necessary to fully review all of the content. Conclusions: Simply providing educational material in a video with animations and voiceovers does not necessarily lead to better engagement from respondents or different preference outcomes in a sample of diabetes patients when compared to text. Increasing engagement with educational materials should be a topic of future research for those conducting patient preference research as no amount of educational material will be helpful if respondents do not access it.
| Original language | English |
|---|---|
| Pages (from-to) | 223-237 |
| Number of pages | 15 |
| Journal | Patient |
| Volume | 16 |
| Issue number | 3 |
| Early online date | 20 Jan 2023 |
| DOIs | |
| Publication status | Published - May 2023 |
Bibliographical note
Funding Information:This study formed part of the PREFER project. The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 115966. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. The PREFER project aims to strengthen patient-centric decision-making through evidence-based recommendations guiding stakeholders on how and when patient preference studies should inform medical product development and evaluation. The authors would like to thank the following people for their help in designing and creating materials for this study: Maria van Dijk-Okla for her help in translating and verifying texts in Polish; Connor Buffel and others from MindBytes for their help in developing the video based educational material; Rimke Vos for her consultation on the survey and educational material content.
Funding Information:
This study formed part of the PREFER project. The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. The PREFER project aims to strengthen patient-centric decision-making through evidence-based recommendations guiding stakeholders on how and when patient preference studies should inform medical product development and evaluation.
Publisher Copyright:
© 2023, The Author(s).
